semaglutide fda news Live Updates on Semaglutide's Current and Future Uses Novo Nordisk gets FDA blessing
Description
REAL TRANSFORMATION
Exenatide reverts the high-Fat-Diet-Induced impairment of BDNF signaling and inflammatory response in an animal model of alzheimers disease
This equates to 5-9 months or more dementia-free days of life
Elevated fasting glucagon concentrations also corresponded to worsened cardiometabolic risk outcomes in another study by the same group, 33 underscoring its potential clinical utility as a predictive biomarker
Did you know its common to lose muscle when dieting
